FCGRT and autoimmune disease: Thus, FcRn antagonism represents a promising treatment strategy for autoantibody-mediated autoimmune diseases by targeting the IgG autoantibody, the end point of the pathogenic humoral immune reaction without significantly suppressing normal immune function.